The Effect of Hyperbaric Oxygen Therapy on Circulating Hematopoietic Stem Cell Population
Recruiting
N/A
Interventional Study
Circulating Hematopoietic Stem Cells
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 20 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Assaf-Harofeh Medical Center · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Hematopoietic stem cells (HSCs), which govern the production of all blood lineages, transition through a series of functional states characterized by expansion during fetal development, functional quiescence in adulthood, and decline upon aging.
Although research on aging has for a long time been relatively descriptive, much progress has been made in the past decade to uncover the molecular drive…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* The study will include patients aged 20-80 who are intendent to start HBOT for other indication that are willing to give blood samples for measurements of circulating stem cells.
Exclusion Criteria:
1. Active or recent infection within the last month
2. Active malignancy.
3.…
Contacts